Cargando…

Regeneration-Associated Transitional State Cells in Pulmonary Fibrosis

Pulmonary fibrosis is a chronic, progressive fibrosing interstitial disease. It is characterized by fibroblast proliferation, myofibroblast activation, and massive extracellular matrix deposition. These processes result in loss of lung parenchyma function. The transdifferentiation of alveolar epithe...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Mengxia, Luo, Ziqiang, Zhou, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223485/
https://www.ncbi.nlm.nih.gov/pubmed/35743199
http://dx.doi.org/10.3390/ijms23126757
_version_ 1784733135230992384
author Shen, Mengxia
Luo, Ziqiang
Zhou, Yan
author_facet Shen, Mengxia
Luo, Ziqiang
Zhou, Yan
author_sort Shen, Mengxia
collection PubMed
description Pulmonary fibrosis is a chronic, progressive fibrosing interstitial disease. It is characterized by fibroblast proliferation, myofibroblast activation, and massive extracellular matrix deposition. These processes result in loss of lung parenchyma function. The transdifferentiation of alveolar epithelial type II (AEC2) to alveolar epithelial type I cells (AEC1) plays an important role in the epithelial repair after lung injury. Pulmonary fibrosis begins when this transdifferentiation process is blocked. Several recent studies have found that novel transitional state cells (intermediate states in the transdifferentiation of AEC2 to AEC1) can potentially regenerate the alveolar epithelium surface and promote a repair process. During the AEC2 to AEC1 trans-differentiation process after injury, AEC2 lose their specific markers and become transitional state cells. Furthermore, transdifferentiation of transitional state cells into AEC1 is the critical step for lung repair. However, transitional cells stagnate in the intermediate states in which failure of transdifferentiation to AEC1 may induce an inadequate repair process and pulmonary fibrosis. In this review, we focus on the traits, origins, functions, and activation of signaling pathways of the transitional state cell and its communication with other cells. We also provide a new opinion on pulmonary fibrosis pathogenesis mechanisms and novel therapeutic targets.
format Online
Article
Text
id pubmed-9223485
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92234852022-06-24 Regeneration-Associated Transitional State Cells in Pulmonary Fibrosis Shen, Mengxia Luo, Ziqiang Zhou, Yan Int J Mol Sci Review Pulmonary fibrosis is a chronic, progressive fibrosing interstitial disease. It is characterized by fibroblast proliferation, myofibroblast activation, and massive extracellular matrix deposition. These processes result in loss of lung parenchyma function. The transdifferentiation of alveolar epithelial type II (AEC2) to alveolar epithelial type I cells (AEC1) plays an important role in the epithelial repair after lung injury. Pulmonary fibrosis begins when this transdifferentiation process is blocked. Several recent studies have found that novel transitional state cells (intermediate states in the transdifferentiation of AEC2 to AEC1) can potentially regenerate the alveolar epithelium surface and promote a repair process. During the AEC2 to AEC1 trans-differentiation process after injury, AEC2 lose their specific markers and become transitional state cells. Furthermore, transdifferentiation of transitional state cells into AEC1 is the critical step for lung repair. However, transitional cells stagnate in the intermediate states in which failure of transdifferentiation to AEC1 may induce an inadequate repair process and pulmonary fibrosis. In this review, we focus on the traits, origins, functions, and activation of signaling pathways of the transitional state cell and its communication with other cells. We also provide a new opinion on pulmonary fibrosis pathogenesis mechanisms and novel therapeutic targets. MDPI 2022-06-17 /pmc/articles/PMC9223485/ /pubmed/35743199 http://dx.doi.org/10.3390/ijms23126757 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Shen, Mengxia
Luo, Ziqiang
Zhou, Yan
Regeneration-Associated Transitional State Cells in Pulmonary Fibrosis
title Regeneration-Associated Transitional State Cells in Pulmonary Fibrosis
title_full Regeneration-Associated Transitional State Cells in Pulmonary Fibrosis
title_fullStr Regeneration-Associated Transitional State Cells in Pulmonary Fibrosis
title_full_unstemmed Regeneration-Associated Transitional State Cells in Pulmonary Fibrosis
title_short Regeneration-Associated Transitional State Cells in Pulmonary Fibrosis
title_sort regeneration-associated transitional state cells in pulmonary fibrosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223485/
https://www.ncbi.nlm.nih.gov/pubmed/35743199
http://dx.doi.org/10.3390/ijms23126757
work_keys_str_mv AT shenmengxia regenerationassociatedtransitionalstatecellsinpulmonaryfibrosis
AT luoziqiang regenerationassociatedtransitionalstatecellsinpulmonaryfibrosis
AT zhouyan regenerationassociatedtransitionalstatecellsinpulmonaryfibrosis